Decoy Therapeutics Statistics
Total Valuation
DCOY has a market cap or net worth of $2.89 million. The enterprise value is -$4.93 million.
Important Dates
The last earnings date was Friday, May 8, 2026, after market close.
| Earnings Date | May 8, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
DCOY has 531,968 shares outstanding. The number of shares has increased by 178.55% in one year.
| Current Share Class | 531,968 |
| Shares Outstanding | 531,968 |
| Shares Change (YoY) | +178.55% |
| Shares Change (QoQ) | +38.99% |
| Owned by Insiders (%) | 0.66% |
| Owned by Institutions (%) | 0.88% |
| Float | 528,439 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.75 |
| P/TBV Ratio | 0.75 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.84
| Current Ratio | 1.84 |
| Quick Ratio | 1.72 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -661.73% and return on invested capital (ROIC) is -143.81%.
| Return on Equity (ROE) | -661.73% |
| Return on Assets (ROA) | -54.13% |
| Return on Invested Capital (ROIC) | -143.81% |
| Return on Capital Employed (ROCE) | -120.21% |
| Weighted Average Cost of Capital (WACC) | 6.33% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.18M |
| Employee Count | 11 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -96.08% in the last 52 weeks. The beta is 0.38, so DCOY's price volatility has been lower than the market average.
| Beta (5Y) | 0.38 |
| 52-Week Price Change | -96.08% |
| 50-Day Moving Average | 6.58 |
| 200-Day Moving Average | 29.83 |
| Relative Strength Index (RSI) | 37.88 |
| Average Volume (20 Days) | 10,460 |
Short Selling Information
The latest short interest is 23,252, so 4.37% of the outstanding shares have been sold short.
| Short Interest | 23,252 |
| Short Previous Month | 19,296 |
| Short % of Shares Out | 4.37% |
| Short % of Float | 4.40% |
| Short Ratio (days to cover) | 0.79 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -4.66M |
| Pretax Income | -13.03M |
| Net Income | -13.03M |
| EBITDA | -4.65M |
| EBIT | -4.66M |
| Earnings Per Share (EPS) | -$57.12 |
Full Income Statement Balance Sheet
The company has $7.82 million in cash and n/a in debt, with a net cash position of $7.82 million or $14.70 per share.
| Cash & Cash Equivalents | 7.82M |
| Total Debt | n/a |
| Net Cash | 7.82M |
| Net Cash Per Share | $14.70 |
| Equity (Book Value) | 3.88M |
| Book Value Per Share | 7.29 |
| Working Capital | 3.81M |
Full Balance Sheet Cash Flow
| Operating Cash Flow | -6.53M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 11,969 |
| Net Borrowing | -112,230 |
| Free Cash Flow | -6.53M |
| FCF Per Share | -$12.28 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
DCOY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -178.55% |
| Shareholder Yield | -178.55% |
| Earnings Yield | -450.38% |
| FCF Yield | -225.81% |
Analyst Forecast
The average price target for DCOY is $30.00, which is 451.47% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $30.00 |
| Price Target Difference | 451.47% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 9, 2026. It was a reverse split with a ratio of 1:12.
| Last Split Date | Mar 9, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:12 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |